Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Cellular Biomedicine Inc
Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc Share News

$18.24 0.2  1.3%

Last Trade - 22/01/21

Sector
Healthcare
RiskRating
Adventurous
Size
Small Cap
Style
Momentum Trap
Market Cap £259.6m
Enterprise Value £275.6m
Revenue £236k
Position in Universe 3725th / 6630
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions CBMG Dividends
All News
All News Reuters News Company Announcements
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference
28th Aug '18 News
BRIEF-Cellular Biomedicine Group Reports Qtrly Loss Per Share $0.53
8th Aug '18 News
Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights
8th Aug '18 News
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland
22nd Jun '18 News
Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia
21st Jun '18 News
BRIEF-Cellular Biomedicine Group Qtrly Loss Per Share $0.51
8th May '18 News
Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
8th May '18 News
Cellular Biomedicine Group Announces Results of 2018 Annual Meeting of Stockholders
30th Apr '18 News
Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders
23rd Mar '18 News
BRIEF-Cellular Biomedicine Announces Positive Clinical Data Of Knee Osteoarthritis China Phase I Trial
16th Mar '18 News
Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin™ Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial
16th Mar '18 News
Cellular Biomedicine Group Announces Upcoming Presentation to Release 48-Week Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy for Knee Osteoarthritis
14th Mar '18 News
BRIEF-Cellular Biomedicine Group Reports Full-Year 2017 Financial Results And Recent Operational Progress
6th Mar '18 News
Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress
6th Mar '18 News
BRIEF-Cellular Biomedicine Files For Resale Of Up To 2.9 Mln Shares By Selling Stockholders ‍​
5th Mar '18 News
Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival
1st Mar '18 News
BRIEF-Cellular Biomedicine Group Announces $30.6 Mln Investment From Sailing Capital Overseas Investment
5th Feb '18 News
BRIEF-Cellular Biomedicine Group Says Enters Securities Purchase Agreement With Certain Investors
31st Jan '18 News
BRIEF-Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility
18th Jan '18 News
BRIEF-Cellular Biomedicine Group reports qtrly loss per share $0.43
9th Nov '17 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.